Harsh Vardhan said that the coronavirus vaccine will be made available in the country by the start of next year; the remarks come at a time when India has recorded more than 5 million cases
Out of 1 million active cases in India, nearly one-third are in Maharashtra
A record single-day increase of 97,894 infections pushed India's COVID-19 tally to over 5.1 million,while the number of people who have recuperated from the disease crossed 4 million on Thursday
Upon regulatory approval in India, RDIF shall supply to Dr. Reddy's 100 million doses of the vaccine
The overall number of global coronavirus cases has topped 29.7 million, while the deaths have increased to over 939,000, according to the Johns Hopkins University
But the administration has also offered timelines for a vaccine that fly in the face of almost every experience in pharmaceutical history
Despite Robert Redfield saying that wearing a mask would be more effective than a vaccine, Trump said that the mask is "not more effective" than the vaccine "by any means"
Talks are also on with five major Indian manufacturers here to produce the vaccine for India and the world
The HC asked an expert panel, set up by the Lieutenant Governor, to convene a meeting on priority basis to consider the extent to which capacity of testing by RT-PCR should be ramped up
Industry says govt makeshift facilities lie vacant as patients scramble for private hospital beds
Study questions therapy's effectiveness in reducing Covid death risks; doctors say helpful in early days
The resumption of trails was allowed after the vaccine maker submitted recommendations of the Data Safety Monitoring Board (DSMB), the UK, and DSMB, India
Coronavirus latest update: DCGI has gave permission to Serum Institute of India to resume clinical trial of the Oxford Covid-19 vaccine candidate. Stay tuned for coronavirus India LIVE updates
The Pentagon is involved with the distribution of vaccines, but civilian health workers will be the ones giving shots
The Russian Direct Investment Fund (RDIF), Russias sovereign wealth fund, and Dr Reddys Laboratories Ltd have agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India
Business Standard brings you the top headlines of the day
The Russian Direct Investment Fund said that the deliveries could potentially begin in late 2020 subject to completion of successful trials and registration of the vaccine in India
Notice to Odisha govt over spread of among tribals, Covid worse than swine flu, one million cases in 11 days--news on how the country is dealing with the pandemic
The Russian Direct Investment Fund added that it had agreed to cooperate on clinical trials and the distribution of the vaccine with the Indian firm
Deliveries could potentially begin in late 2020 subject to completion of successful trials and registration of the vaccine by regulatory authorities in India, Dr Reddy's said in a statement